ChemiDoc MP Imaging System

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FOOD AND DRUG ADMINISTRATION

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00415

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

SBA

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation for the procurement of a ChemiDoc MP Imaging System. This opportunity, identified by procurement number 75F40126Q00415, is classified under NAICS code 334516, which pertains to Analytical Laboratory Instrument Manufacturing, and is further designated by Product Service Code 6640. The primary objective of this procurement is to acquire a ChemiDoc MP Imaging System to support the FDA’s laboratory operations in Silver Spring, Maryland. The ChemiDoc MP Imaging System is a specialized analytical instrument used for imaging and analyzing gels and blots, which are essential processes in molecular biology and analytical chemistry. The intended outcome of this acquisition is to enhance the FDA’s analytical capabilities, supporting its mission to ensure public health and safety through rigorous scientific analysis. This solicitation is set aside for Small Business Administration (SBA) eligible vendors, indicating that only qualified small businesses are invited to submit proposals. Interested contractors should ensure they meet the SBA set-aside requirements before responding. Key requirements and expected deliverables include the provision and delivery of a fully functional ChemiDoc MP Imaging System to the FDA’s facility in Silver Spring, Maryland. While the specific technical specifications and performance requirements are detailed in the attached documents referenced in the notice, contractors should be prepared to supply a system that meets the FDA’s high standards for laboratory instrumentation, including reliability, accuracy, and compliance with applicable regulatory standards. The procurement is being managed by the FDA’s contracting office, with Janice Heard serving as the primary point of contact. Prospective offerors may direct inquiries to Ms. Heard via email at [email protected] or by phone at 215-717-3093. The notice was posted on October 9, 2026, and responses are due by September 15, 2026, at 18:09. Interested parties are encouraged to review the full solicitation and any attachments available through the official SAM.gov opportunity listing (https://sam.gov/opp/a206123cc47449f7b65fdaad90159bfd/view) to ensure a comprehensive understanding of the requirements and submission procedures. In summary, this procurement represents an opportunity for qualified small business manufacturers and suppliers of analytical laboratory instruments to provide a critical piece of equipment to the FDA. The successful contractor will play a vital role in supporting the agency’s scientific and regulatory functions at its Silver Spring, Maryland location.